Potencial herramienta en la personalización del tratamiento oncológico: Casos clínicos

Our laboratory has implemented an in vitro assay to estimate the response to chemotherapy in ovarian cancer cells pertaining to individual patients. In two selected patients, we determined the correlation between an in vitro assay of cells from suspected ovarian cancer ascites, with the clinical che...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ibáñez C,Carolina, Garrido S,Marcelo, Medina,Lidia, Kato,Sumie, Bravo,María Loreto, González,Pamela, Oliva,Barbara, Pizarro,Javier, Bustamante,Eva, Brañes,Jorge, Cuello,Mauricio, Owen,Gareth I
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2013
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000500017
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Our laboratory has implemented an in vitro assay to estimate the response to chemotherapy in ovarian cancer cells pertaining to individual patients. In two selected patients, we determined the correlation between an in vitro assay of cells from suspected ovarian cancer ascites, with the clinical chemotherapy response. Cancer cells isolated from peritoneal fluid with suspected ovarian cancer were tested for cytotoxicity with corresponding chemotherapy regimens. Circulating Cal25 levels and attending physician consultation determined clinical course and response to chemotherapy. The in vitro assay result correlated with Cal25 levels, progression free survival and attending physician evaluation. The assay predicted correctly the failure of two successive chemotherapy regimes in the first patient, while predicting a favorable clinical response in the second subject.